Barostim Neo System
Payments companies reported to CMS as associated with Barostim Neo System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Barostim Neo System, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Barostim Neo System
These are the largest totals companies reported as associated with Barostim Neo System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Gurusher Panjrath | Washington, DC | Advanced Heart Failure and Transplant Cardiology | $165,210.62 |
| Patrick Mccann | Columbia, SC | Advanced Heart Failure and Transplant Cardiology | $141,304.00 |
| Dmitry Yaranov | Memphis, TN | Advanced Heart Failure and Transplant Cardiology | $133,682.83 |
| Joseph Rahman | Los Angeles, CA | Advanced Heart Failure and Transplant Cardiology | $97,770.22 |
| Amarinder Bindra | Dallas, TX | Cardiovascular Disease | $82,665.68 |
| Manuel Perez Izquierdo | Orlando, FL | Vascular Surgery | $79,426.83 |
| Nirav Raval | Orlando, FL | Cardiovascular Disease | $79,225.88 |
| Albert Hicks | Temple, TX | Advanced Heart Failure and Transplant Cardiology | $72,748.55 |
| Christina Economides | Los Angeles, CA | Interventional Cardiology | $60,804.86 |
| Rachel Garcia | Cincinnati, OH | Advanced Heart Failure and Transplant Cardiology | $59,224.28 |
Prescribed Barostim Neo System?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.